EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention

Ana Luz Tobaruela-Resola, José Ignacio Riezu-Boj, Fermín I Milagro, Paola Mogna-Pelaez, José I Herrero, Mariana Elorz, Alberto Benito-Boillos, Josep A Tur, J Alfredo Martínez, Itziar Abete, María Ángeles Zulet

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02499-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von Ana Luz Tobaruela-Resola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Food Sciences and Physiology, Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008…. Hauptthemen laut MEDLINE: Biomarkers, Circulating MicroRNA, Fatty Liver, MicroRNAs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) affects one-third of the global population. Despite its high prevalence, there is a lack of minimally non-invasive diagnostic methods to assess this condition. This study explores the potential of circulating microRNAs (miRNAs) as diagnostic biomarkers for MASLD after a 2-year nutritional intervention.

Methods

Fifty-five subjects with steatosis (MASLD group) from the Fatty Liver in Obesity (FLiO) study (NCT03183193) were analyzed at baseline and after 6, 12 and 24 months. Participants were classified into two groups: those who still had steatosis after the intervention (unhealthy group) and those in whom steatosis had disappeared (healthy group). Hepatic status was evaluated through magnetic resonance imaging (MRI), ultrasonography, elastography and serum transaminases. Circulating miRNA levels were measured by RT-PCR.

Results

The dietary intervention was able to modulate the expression of circulating miRNAs after 6, 12, and 24 months. Logistic regression analyses revealed that the most effective panels for diagnosing whether MASLD has disappeared after the nutritional intervention included miR15b-3p, miR126-5p and BMI (AUC 0.68) at 6 months, miR29b-3p, miR122-5p, miR151a-3p and BMI (AUC 0.85) at 12 months and miR21-5p, miR151a-3p and BMI at 24 months (AUC 0.85).

Conclusions

Circulating miRNAs were useful in predicting MASLD in subjects with overweight or obesity after following a weight-loss oriented nutritional intervention. These findings highlight the potential role of miRNAs in diagnosing MASLD and underscore the importance of precision nutrition in managing and determining MASLD. Clinical trial registration Trial registration number: NCT03183193 (www.clinicaltrials.gov).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCirculating MicroRNAFatty LiverMicroRNAsNon-alcoholic Fatty Liver DiseaseObesityAdultFemaleHumansMaleMiddle AgedFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

BiomarkerFatty liverMASLDMiRNANAFLDNutritional intervention

Substanzen

BiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Nutrition, Food Sciences and Physiology, Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008, Pamplona, Spain.
  • Navarra Institute for Health Research (IdiSNA), 31008, Pamplona, Spain.
  • Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Liver Unit, Clínica Universidad de Navarra, 31008, Pamplona, Spain.
  • Biomedical Research Centre Network in Hepatic and Digestive Diseases (CIBERehd), 28029, Madrid, Spain.
  • Department of Radiology, Clínica Universidad de Navarra, 31008, Pamplona, Spain.

Förderung

  • Universidad de Navarra

Zitieren

APA

Tobaruela-Resola, A. L., Riezu-Boj, J. I., Milagro, F. I., Mogna-Pelaez, P., Herrero, J. I., Elorz, M., Benito-Boillos, A., Tur, J. A., Martínez, J. A., Abete, I., & Zulet, M. Á. (2024). Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02499-9

Vancouver

Tobaruela-Resola AL, Riezu-Boj JI, Milagro FI, Mogna-Pelaez P, Herrero JI, Elorz M, et al. Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02499-9

BibTeX
@article{TobaruelaResola2024,
  author = {Tobaruela-Resola, Ana Luz and Riezu-Boj, José Ignacio and Milagro, Fermín I and Mogna-Pelaez, Paola and Herrero, José I and Elorz, Mariana and Benito-Boillos, Alberto and Tur, Josep A and Martínez, J Alfredo and Abete, Itziar and Zulet, María Ángeles},
  title = {Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02499-9}
}
Kostenlos starten →